InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: F1ash post# 2418

Thursday, 03/23/2017 7:33:24 AM

Thursday, March 23, 2017 7:33:24 AM

Post# of 21531
After I posted that I regretted not including Alzheimers along with the other 4 words. I wasn't allowed to correct the post. The neurologist that reviewed Neurotrope's clinical trials and MOA didn't say unregulated synaptogenesis may increase the incidence of severe seizures and severe behavioral and pscyhe disturbances in patients with Alzheimers based on nothing. He learned that during his studies. He didn't tell me that for the hell of it based on nothing. He didn't invent it. He has no axe to grind against NTRP. He told me the drug induced increased seizures and psyche disturbance can actually be worse from a morbidity (suffering) and mortality standpoint than the cognitive decline experienced with Alzheimers. Keep in mind, every time you have a severe seizure there is brain damage that occurs. Epileptic disorders lead to more than just intermittent seizure events. There are other permanent ramifications and loss of function, such as cognitive damage.

Cancer patients are irrelevant unless they have Alzheimers. I'm not aware that unregulated synaptogenesis increases risk of seizures and psyche disturbances in cancer patients, like it can in Alzheimers patients.

Dr Alkon published a lot of papers on bryostatin, a paper hyping it for treating cancer or HIV and then another reporting its failure. Rinse repeat X39. Now he's writing papers hyping it for yet another indication. He needs vindication to redeem himself. Alkon is like A LOT of researchers, probably the bulk of them. Their drug of study is like their baby. It can do no wrong and no one can say a bad word against it no matter what. Bryostatin is Alkon's career, more than that, it IS his identity, his obsession, and life's purpose. If it were to fail, yet again, he would be crushed. He would feel like his entire career was all for naught and feel like a failure himself. And so he protects himself by wearing blinders (Like a lot of investors I might add). They lose objectivity and dismiss anything they do not want to hear. They have drunk the Kool Aid so to speak and fallen under its spell.

There is A LOT to criticize bryostatin and Neurotrope for, but you won't hear it here cept from me and Xena. In the Anavex Facebook groups investors question the drug and company to put them to the test and hold them accountable and under scrutiny, without spreading conjecture, speculation, and FUD I might add. I see you F1ash doing that ad infinitum everyday on the AVXL ihub page but narry a peep of criticism from you towards NTRP and bryostatin. Are they that pure as the driven snow?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News